(Q73162400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

J P Marissal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Selke

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Lebrun

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

185-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11067652%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-200018020-00008

1 November 2019

exact match

0 references

cites work

Accounting for future costs in medical cost-effectiveness analysis

1 reference

12 December 2020

Cost of stroke in The Netherlands from a societal perspective

1 reference

12 December 2020

Audit of secondary prophylaxis after myocardial infarction

1 reference

12 December 2020

Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disea

1 reference

12 December 2020

On the decision rules of cost-effectiveness analysis.

1 reference

12 December 2020

Controlled trial of aspirin in cerebral ischemia: an addendum

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems.

1 reference

12 December 2020

Controlled trial of aspirin in cerebral ischemia. Part II: surgical group

1 reference

12 December 2020

Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study

1 reference

12 December 2020

Direct medical costs of coronary artery disease in the United States.

1 reference

12 December 2020

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group

1 reference

12 December 2020

Aspirin and secondary mortality after myocardial infarction

1 reference

12 December 2020

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

1 reference

12 December 2020

Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole

1 reference

12 December 2020

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

12 December 2020

An economic analysis of ischaemic heart disease in Switzerland.

1 reference

12 December 2020

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

1 reference

12 December 2020

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

1 reference

12 December 2020

Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project.

1 reference

12 December 2020

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

1 reference

12 December 2020

Costs and effects of long-term oral anticoagulant treatment after myocardial infarction.

1 reference

12 December 2020

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

12 December 2020

Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction.

1 reference

12 December 2020

Preventing fatal diseases increases healthcare costs: cause elimination life table approach

1 reference

12 December 2020

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group

1 reference

12 December 2020

Danish very-low-dose aspirin after carotid endarterectomy trial.

1 reference

12 December 2020

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

12 December 2020

The economic impact of the tacrine in the treatment of Alzheimer's disease

1 reference

12 December 2020

Controlled trial of aspirin in cerebral ischemia

1 reference

12 December 2020

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

1 reference

12 December 2020

Economic foundations of cost-effectiveness analysis

1 reference

12 December 2020

Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach

1 reference

12 December 2020

Theoretical issues in cost-effectiveness analysis

1 reference

12 December 2020

The results of CAPRIE, IST and CAST. Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events. International Stroke Trial. Chinese Acute Stroke Trial.

1 reference

12 December 2020

An economic evaluation of donepezil in the treatment of Alzheimer's disease.

1 reference

12 December 2020

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group

1 reference

12 December 2020

Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysis.

1 reference

12 December 2020

Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.

1 reference

12 December 2020

[Socio-occupational future of patients treated for myocardial infarction]

1 reference

12 December 2020

Treatment of Alzheimer disease with tacrine: a cost-analysis model.

1 reference

12 December 2020

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

12 December 2020

Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden

1 reference

12 December 2020

Is aspirin underused in myocardial infarction?

1 reference

12 December 2020

ASHP therapeutic position statement on the use of aspirin for prophylaxis of myocardial infarction

1 reference

12 December 2020

Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators

1 reference

12 December 2020

Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989.

1 reference

12 December 2020

Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.

1 reference

12 December 2020

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin.

1 reference

12 December 2020

United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group

1 reference

12 December 2020

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

1 reference

12 December 2020

Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events

1 reference

12 December 2020

Aspirin in coronary heart disease. The Coronary Drug Project Research Group

1 reference

12 December 2020

A randomized, controlled trial of aspirin in persons recovered from myocardial infarction

1 reference

12 December 2020